InvestorsHub Logo
Followers 62
Posts 7555
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Tuesday, 06/04/2024 3:10:02 PM

Tuesday, June 04, 2024 3:10:02 PM

Post# of 426447
It is now my belief that we will see an announcement of an AG for Vascepa by the end of June...Holt had no experience in dealing with the U.S. FDA and with marketing in the U.S... and he graciously ceded the CEO position to Berg in this critical time for Amarin....Berg does have experience with the FDA and with marketing...The CEO job for Amarin has now switched from getting Vascepa approved in Europe...to getting Vascepa approved by the FDA in the U.S...and then to market an AG in the U.S....both formidable challenges.

It is a job that was more suited to Berg's skills and experience than to Holt's...Holt understood the situation and appropriately resigned.

Berg's long affiliation with Amarin as a marketer will be helpful in accomplishing Amarin's goals.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News